Varshney Sandesh, Alam Md Aftab, Kaur Awaneet, Dhoundiyal Shivang
Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India.
Pharm Nanotechnol. 2024;12(2):108-125. doi: 10.2174/2211738511666230524143832.
Niosomes are lipid-based nanovesicles that have the potential to act as drug-delivery vehicles for a variety of agents. They are effective drug delivery systems for both ASOs and AAV vectors, with advantages such as improved stability, bioavailability, and targeted administration. In the context of brain-targeted drug delivery, niosomes have been investigated as a drug delivery system for brain targeting, but more research is needed to optimize their formulation to improve their stability and release profile and address the challenges of scale-up and commercialization. Despite these challenges, several applications of niosomes have demonstrated the potential of novel nanocarriers for targeted drug delivery to the brain. This review briefly overviews the current use of niosomes in treating brain disorders and diseases.
非离子表面活性剂泡囊是基于脂质的纳米囊泡,有潜力作为多种药物的递送载体。它们是用于反义寡核苷酸(ASO)和腺相关病毒(AAV)载体的有效药物递送系统,具有诸如提高稳定性、生物利用度和靶向给药等优点。在脑靶向给药的背景下,非离子表面活性剂泡囊已作为脑靶向的药物递送系统进行了研究,但需要更多研究来优化其配方,以提高其稳定性和释放特性,并解决扩大规模和商业化的挑战。尽管存在这些挑战,但非离子表面活性剂泡囊的一些应用已证明新型纳米载体用于脑靶向给药的潜力。本综述简要概述了非离子表面活性剂泡囊目前在治疗脑部疾病和病症中的应用。